(Q58974278)
Statements
Confirmation of administrative claims-identified opportunistic infections and other serious potential adverse events associated with tumor necrosis factor alpha antagonists and disease-modifying antirheumatic drugs (English)
Curtis JR
Martin C
Saag KG
Patkar NM
Kramer J
Shatin D